These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3121288)

  • 1. Effect of two administration schedules of an enteral nutrient formula on phenytoin bioavailability.
    Krueger KA; Garnett WR; Comstock TJ; Fitzsimmons WE; Karnes HT; Pellock JM
    Epilepsia; 1987; 28(6):706-12. PubMed ID: 3121288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of phenytoin acid and phenytoin sodium with enteral feedings.
    Doak KK; Haas CE; Dunnigan KJ; Reiss RA; Reiser JR; Huntress J; Altavela JL
    Pharmacotherapy; 1998; 18(3):637-45. PubMed ID: 9620116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative bioavailability of orally administered fosphenytoin sodium injection compared with phenytoin sodium injection in healthy volunteers.
    Kaucher KA; Acquisto NM; Rao GG; Kaufman DC; Huntress JD; Forrest A; Haas CE
    Pharmacotherapy; 2015 May; 35(5):482-8. PubMed ID: 26011141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of enteral feeding on the oral bioavailability of moxifloxacin in healthy volunteers.
    Burkhardt O; Stass H; Thuss U; Borner K; Welte T
    Clin Pharmacokinet; 2005; 44(9):969-76. PubMed ID: 16122283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of salivary drug monitoring for detecting efflux transporter overexpression.
    Fagiolino P; Vázquez M; Maldonado C; Ruiz ME; Volonté MG; Orozco-Suárez S; Lazarowski A
    Curr Pharm Des; 2013; 19(38):6701-8. PubMed ID: 23530513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between phenytoin and enteral nutrients and its influence on gastrointestinal absorption.
    Urashima Y; Urashima K; Ohnishi M; Matsushita K; Suzuki K; Kurachi K; Nishihara M; Katsumata T; Myotoku M; Ikeda K; Hirotani Y
    Pharmazie; 2019 Sep; 74(9):559-562. PubMed ID: 31484597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excretion of the principal urinary metabolites of phenytoin and absolute oral bioavailability determined by use of a stable isotope in patients with epilepsy.
    Aliwarga T; Cloyd JC; Goel V; Brundage RC; Marino SE; Leppik IE; Remmel RP
    Ther Drug Monit; 2011 Feb; 33(1):56-63. PubMed ID: 21233690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute bioavailability of phenytoin after 3-phosphoryloxymethyl phenytoin disodium (ACC-9653) administration to humans.
    Jamerson BD; Donn KH; Dukes GE; Messenheimer JA; Brouwer KL; Powell JR
    Epilepsia; 1990; 31(5):592-7. PubMed ID: 2401249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic profile of a 300-mg extended phenytoin sodium capsule (Dilantin) formulation.
    Randinitis EJ; Buchanan RA; Kinkel AW
    Epilepsia; 1990; 31(4):458-64. PubMed ID: 2369880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasogastric administration of garenoxacin as crushed tablets with and without concomitant enteral feeding in healthy subjects.
    Krishna G; Noveck R; Vargas R; Grasela D; Wang Z
    Drugs R D; 2007; 8(1):43-50. PubMed ID: 17249848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of an enteral nutrient formula on sustained-release theophylline absorption.
    Bhargava VO; Schaaf LJ; Berlinger WG; Jungnickel PW
    Ther Drug Monit; 1989 Sep; 11(5):515-9. PubMed ID: 2510372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vigabatrin-induced decrease in serum phenytoin concentration does not involve a change in phenytoin bioavailability.
    Gatti G; Bartoli A; Marchiselli R; Michelucci R; Tassinari CA; Pisani F; Zaccara G; Timmings P; Richens A; Perucca E
    Br J Clin Pharmacol; 1993 Dec; 36(6):603-6. PubMed ID: 12959280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coadministration of phenytoin and felbamate: evidence of additional phenytoin dose-reduction requirements based on pharmacokinetics and tolerability with increasing doses of felbamate.
    Sachdeo R; Wagner ML; Sachdeo S; Shumaker RC; Lyness WH; Rosenberg A; Ward D; Perhach JL
    Epilepsia; 1999 Aug; 40(8):1122-8. PubMed ID: 10448826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of an elemental and a complex enteral feeding formulation on the absorption of phenytoin suspension.
    Marvel ME; Bertino JS
    JPEN J Parenter Enteral Nutr; 1991; 15(3):316-8. PubMed ID: 1907681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antacids on phenytoin bioavailability.
    Carter BL; Garnett WR; Pellock JM; Stratton MA; Howell JR
    Ther Drug Monit; 1981; 3(4):333-40. PubMed ID: 7336470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral absorption kinetics of levetiracetam: the effect of mixing with food or enteral nutrition formulas.
    Fay MA; Sheth RD; Gidal BE
    Clin Ther; 2005 May; 27(5):594-8. PubMed ID: 15978308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective 4'-hydroxylation of phenytoin: relationship to (S)-mephenytoin polymorphism in Japanese.
    Ieiri I; Mamiya K; Urae A; Wada Y; Kimura M; Irie S; Amamoto T; Kubota T; Yoshioka S; Nakamura K; Nakano S; Tashiro N; Higuchi S
    Br J Clin Pharmacol; 1997 Apr; 43(4):441-5. PubMed ID: 9146858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of enteral feedings on phenytoin sodium absorption from capsules.
    Nishimura LY; Armstrong EP; Plezia PM; Iacono RP
    Drug Intell Clin Pharm; 1988 Feb; 22(2):130-3. PubMed ID: 3127188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of acute and chronic terfenadine on free and total serum phenytoin concentrations in epileptic patients.
    Coniglio AA; Garnett WR; Pellock JH; Tsidonis O; Hepler CD; Serafin R; Small RE; Driscoll SM; Karnes HT
    Epilepsia; 1989; 30(5):611-6. PubMed ID: 2571498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenytoin pharmacokinetics following oral administration of phenytoin suspension and fosphenytoin solution to rats.
    Burstein AH; Cox DS; Mistry B; Eddington ND
    Epilepsy Res; 1999 Apr; 34(2-3):129-33. PubMed ID: 10210027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.